Regulatory control of the Na–Cl co-transporter NCC and its therapeutic potential for hypertension NFM Azlan, MP Koeners, J Zhang Acta Pharmaceutica Sinica B 11 (5), 1117-1128, 2021 | 36 | 2021 |
WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension A Brown, NF Meor Azlan, Z Wu, J Zhang Acta Pharmacologica Sinica 42 (4), 508-517, 2021 | 24 | 2021 |
Targeting the WNK-SPAK/OSR1 pathway and cation-chloride cotransporters for the therapy of stroke SS Josiah, NF Meor Azlan, J Zhang International Journal of Molecular Sciences 22 (3), 1232, 2021 | 22 | 2021 |
Role of the cation-chloride-cotransporters in cardiovascular disease NF Meor Azlan, J Zhang Cells 9 (10), 2293, 2020 | 14 | 2020 |
NF-κB Signaling-Mediated Activation of WNK-SPAK-NKCC1 Cascade in Worsened Stroke Outcomes of Ang II–Hypertensive Mice MIH Bhuiyan, CB Young, I Jahan, MN Hasan, S Fischer, NF Meor Azlan, ... Stroke 53 (5), 1720-1734, 2022 | 13 | 2022 |
Role of the cation-chloride-cotransporters in the circadian system S Salihu, NFM Azlan, SS Josiah, Z Wu, Y Wang, J Zhang Asian Journal of Pharmaceutical Sciences 16 (5), 589-597, 2021 | 9 | 2021 |
The role of SLC12A family of cation-chloride cotransporters and drug discovery methodologies S Zhang, NFM Azlan, SS Josiah, J Zhou, X Zhou, L Jie, Y Zhang, C Dai, ... Journal of Pharmaceutical Analysis, 2023 | 7 | 2023 |
Angiotensin II receptor blockers in the management of hypertension in preventing cognitive impairment and dementia—A systematic review E D’Silva, NF Meor Azlan, J Zhang Pharmaceutics 14 (10), 2123, 2022 | 6 | 2022 |
Study of the functions and activities of neuronal K-Cl co-transporter KCC2 using western blotting SS Josiah, NFM Azlan, A Oguro-Ando, J Zhang JoVE (Journal of Visualized Experiments), e64179, 2022 | 1 | 2022 |